PROPOSED LISTING OF CELL C HOLDINGS LIMITED ON THE MAIN BOARD OF THE JSE LIMITED AND ABRIDGED PRE-LISTING STATEMENT THE ABRIDGED PRE-LISTING STATEMENT DOES NOT CONSTITUTE AN OFFER TO ANY PERSON IN ANY ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...

Alzheimer's disease (AD), the leading cause of dementia, affects nearly 40 million individuals globally, resulting in a ...

Detailed price information for Alnylam Pharmaceuticals (ALNY-Q) from The Globe and Mail including charting and trades.

In February 1953, two men walked into a pub in Cambridge and announced they had found "the secret of life". It was not an ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the Phase 3 ASCENT-07 study investigating Trodelvy® (sacituzumab ...

Secretin regulates Ca²⁺ signaling in interstitial cells of Cajal in the deep muscular plexus (ICC-DMP), revealing a targeted hormonal pathway that slows small intestinal transit to support nutrient ...

Nucleome Therapeutics ('Nucleome' or 'the Company'), an immunology company tackling the root causes of disease through a revolutionary new approach to solving human genetics, is delighted that its ...

Priority Research Communication by Professor Yogesh Dwivedi and colleagues at the University of Alabama at Birmingham reports original, peer-reviewed findings demonstrating that long noncoding RNAs ...

This latest pattern emphasizes competency-based learning, focusing on conceptual understanding, analytical thinking, and ...

-- STK-012 is an <ALPHA>/<BETA> biased IL-2 designed to specifically stimulate antigen activated T cells -- Results from an ongoing Phase 1a/1b to be presented at SITC -- Company will also present new ...